Other languages REGENXBIO Inc.

Equities

RGNX

US75901B1070

Market Closed - Nasdaq Other stock markets 04:00:03 2024-05-31 pm EDT			5-day change	1st Jan Change
14.34 ^USD	-0.07%		-3.89%	-20.11%

May. 15	Transcript : REGENXBIO Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM
May. 15	HC Wainwright Adjusts Price Target on REGENXBIO to $38 From $36, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : REGENXBIO Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	May. 15
HC Wainwright Adjusts Price Target on REGENXBIO to $38 From $36, Maintains Buy Rating	May. 15
Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	May. 15
REGENXBIO to Participate in Upcoming Investor Conferences	May. 13
REGENXBIO to Participate in Upcoming Investor Conferences	May. 10
UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating	May. 09
Regenxbio: Q1 Earnings Snapshot	May. 08
Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
Earnings Flash (RGNX) REGENXBIO Posts Q1 Revenue $15.6M	May. 08
REGENXBIO Inc. Announces Consolidated Impairment Charges for the First Quarter Ended March 31, 2024	May. 08
REGENXBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights	May. 01
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	Apr. 24
REGENXBIO And Sarepta Agree To Stay Litigation Pending Outcome Of Sarepta's IPR Petition	Apr. 04
One-time gene therapy could improve wet AMD	Apr. 01
REGENXBIO Inc. Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD	Mar. 28
REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days	Mar. 27
Transcript : REGENXBIO Inc. Presents at UBS Virtual CNS Day 2024, Mar-18-2024 03:30 PM	Mar. 18
Transcript : REGENXBIO Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 through Mar-14-2024	Mar. 13
HC Wainwright Initiates REGENXBIO With Buy Rating, $36 Price Target	Mar. 11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages REGENXBIO Inc.

Equities

RGNX

US75901B1070

Other languages

Filters